|
Mj Biotech, Inc.
The shareholders have not assumed any changes at the business during the the earnings cycle of fiscal October to December 31 2018 at the Mj Biotech, Inc.. Yet, they observe the Internet Services & Social Media company's operating surplus which has been at $5.761972 millions, during the same period.
Mj Biotech, Inc. Customers
Mj Biotech, Inc. improvement Rates, Profitability, PE
Ascent Industries Co
For the fiscal fourth quarter of 2022 Ascent Industries Co income fell sharply by -98.68 % of $0.01 per share compare to $0.82 a year prior and earnings per share dropped by -81.86 % from $0.06 per share from the previous quarter.
Revenues declined respectably by -14.747 % to $81.56 millions from $95.67 millions in the same quarter a year prior and sequentially Revenues fell by -18.576 % from $100.17 millions.
Ascent Industries Co Suppliers
Ascent Industries Co Revenue elevation Rates
|
Reading International Inc
For the fiscal period ending December 31 2022 RDI posted a shortfall per stock of $-0.54 per share compare to $0.02 a year prior and grew shortfall from $-0.23 per share from the preceding financial reporting period.
Revenues decreased by -5.427 % to $47.21 millions from $49.92 millions in the corresponding financial reporting period a year prior and sequentially Revenue deteriorated by -7.79 % from $51.20 millions.
Reading International Inc Customers
Reading International Inc advance Rates, Profitability, PE
|
|
Recently Reported Results |
Aspira Women S Health Inc
For the most recent fiscal period AWH lost money of $-0.04 per share compare to $-0.08 a year prior and from $-0.04 per share from the prior reporting season.
Revenues rose extensively by 16.316 % to $2.15 millions from $1.85 millions in the corresponding reporting season a year prior and sequentially Revenues advanced by 3.909 % from $2.07 millions.
Aspira Women S Health Inc Competitors, Market Share
Aspira Women S Health Inc Income Statement, Balance sheets, Cash Flow Statement
|
Quaint Oak Bancorp Inc
For the most recent fiscal period company net profit per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year ago and profit plummeted by -55.19 % from $1.22 per share from the previous financial reporting period.
Revenues sunk by -6.343 % to $8.80 millions from $9.40 millions in the similar financial reporting period a year ago and sequentially Revenues fell by -26.514 % from $11.98 millions.
Quaint Oak Bancorp Inc Customers
Quaint Oak Bancorp Inc Suppliers
|
Socket Mobile Inc
In the financial fourth quarter of 2022 the company disclosed soft top and bottom-line, where reached balanced books and revenue by -15.427 % year on year. Revenue were to $5.17 millions relative to $6.11 millions eps at $0.00 compared to $0.09 in the financial period ending December 31 2021.
Socket Mobile Inc Customers
Socket Mobile Inc advance Rates, Profitability, PE
|
Better Therapeutics Inc
While the October to December 31 2022 reporting cycle continues, many entities have announced the results. Some of them, have been various constituents of the Medical Equipment & Supplies industry. As well as, today, BTTX announced operating shortfall of $-8.322 millions, for the financial period ending December 31 2022.
Better Therapeutics Inc Competitors, Market Share
Better Therapeutics Inc Revenue elevation Rates
|
Aptevo Therapeutics Inc
For the October to December 31 2022 period company decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and Income per Share improved from $-1.50 per share from the preceding reporting season.
Revenues remained unchanged to $0.00 millions from $3.67 millions in the same reporting season a year prior and sequentially Revenues surged from $0.00 millions.
Aptevo Therapeutics Inc Customers
Aptevo Therapeutics Inc Revenue growth Rates
|
Candel Therapeutics Inc
Underlining the fourth quarter of 2022 CADL Losses have swelled at $-0.15 per share, relative to the earnings of $1.54 per share a year ago financial reporting period, In the previous financial reporting period CADL realized $-0.30 per share.
Candel Therapeutics Inc Competitors, Market Share
Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement
|
|
|
|
Recently Reported Results |
Mj Biotech, Inc.
The Internet Services & Social Media industry contributors continue to scrutinize the fourth quarter of 2018 results. Now those contributors observe operating income of $5.761972 millions, from the Mj Biotech, Inc., as it has not specified any revenue still, for the own October to December 31 2018 reporting period.
Mj Biotech, Inc. Customers
Mj Biotech, Inc. Suppliers
|
Construction Spending
Outlays for U.S. construction projects increased again after dipping in the last month, led by growth in construction outlays for health care, residential and nonresidential construction.
Construction spending by category
Growth in construction outlays
|
Aei Income And Growth Fund Xxi Limited Partnership
For the fourth quarter of 2022 company bottom-line turned positive of $0.01 per share compare to $-0.14 a year ago and Income per Share dropped by -99.63 % from $1.64 per share from the preceding financial reporting period.
Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the comparable financial reporting period a year ago and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.
Aei Income And Growth Fund Xxi Limited Partnership Competitors, Market Share
Aei Income And Growth Fund Xxi Limited Partnership Suppliers
|
Creative Media And Community Trust Corporation
For the financial fourth quarter of 2022 Creative Media And Community Trust Corporation Diminishing Returns have swelled of $-0.39 per share compare to $-0.38 a year before and Income per Share improved from $-0.50 per share from the preceding financial reporting period.
Revenue grew moderately by 2.957 % to $25.87 millions from $25.13 millions in the corresponding financial reporting period a year before and sequentially Revenues surged by 4.084 % from $24.85 millions.
Creative Media And Community Trust Corporation Customers
Creative Media And Community Trust Corporation Suppliers
|
Aspira Women S Health Inc
For the most recent fiscal period company lost money of $-0.04 per share compare to $-0.08 a year ago and from $-0.04 per share from the prior reporting season.
Revenues rose considerably by 16.316 % to $2.15 millions from $1.85 millions in the similar reporting season a year ago and sequentially Revenues grew by 3.909 % from $2.07 millions.
Aspira Women S Health Inc Customers
Aspira Women S Health Inc growth Rates, Profitability, PE
|
Consumer Price Index
U.S. Consumer prices rose again after dipping in the last month, led by increase in gasoline prices.
|
Employment Report
The nonfarm payrolls grew 223,000 in December, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,
|
Housing Starts
|
Quaint Oak Bancorp Inc
For the most recent fiscal period Quaint Oak Bancorp Inc earnings per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year before and profit plummeted by -55.19 % from $1.22 per share from the prior reporting period.
Revenues decreased by -6.343 % to $8.80 millions from $9.40 millions in the comparable reporting period a year before and sequentially Revenues fell by -26.514 % from $11.98 millions.
Quaint Oak Bancorp Inc stock quotes, charts, profile
Quaint Oak Bancorp Inc Revenue improvement Rates
|
Socket Mobile Inc
In the most recent fiscal period the company reported soft top and bottom-line, where reached 0 and revenue by -15.427 % year on year. Revenue were to $5.17 millions in proportion to $6.11 millions eps at $0.00 in contrast to $0.09 in fourth quarter of 2021.
Socket Mobile Inc stock quotes, charts, profile
Socket Mobile Inc Income Statement, Balance sheets, Cash Flow Statement
|
Better Therapeutics Inc
After the large companies in the Medical Equipment & Supplies sector, a number of overlooked businesses are impending with the earnings. BTTX said it has announced operating shortfall of $-8.322 millions, for the fourth quarter of 2022.
Better Therapeutics Inc Customers
Better Therapeutics Inc advance Rates, Profitability, PE
|
Aptevo Therapeutics Inc
For the most recent fiscal period Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and Income per Share improved from $-1.50 per share from the previous quarter.
Revenues remained unaltered to $0.00 millions from $3.67 millions in the same quarter a year prior and sequentially Revenues surged from $0.00 millions.
Aptevo Therapeutics Inc Customers
Aptevo Therapeutics Inc Revenue improvement Rates
|
Candel Therapeutics Inc
Directing the attention to the financial period closing Dec 31 2022 CADL Deficit has expanded at $-0.15 per share, relative to the recent numbers of $1.54 per share a year before reporting period, In the preceding reporting period CADL realized $-0.30 per share.
Candel Therapeutics Inc Customers
Candel Therapeutics Inc Revenue rise Rates
|
Invesco Db G10 Currency Harvest Fund
In the financial three months ending December 31 2022 Invesco Db G10 Currency Harvest Fund reached break-even at $0.00 per share, opposite of $0.00 per share a year ago financial reporting period, In the preceding financial reporting period DBV realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile
Invesco Db G10 Currency Harvest Fund Suppliers
|
|
|
|
|